OMC Clinical Researchsp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2018-04-25
Share capital
50,000.00 PLN
Registered address
ul. Ks. Zygmunta Trybowskiego 14, 85-796 Bydgoszcz, Poland
Financials
Revenue history
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 557 days for 2020).
- 2025not filed
- 202424/09/2025
- 202324/09/2025
- 202225/05/2023
- 202125/05/2023
- 202025/04/2023
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
- Manufacture of pharmaceutical preparations (21.2)
Authorized Representatives
Karolina Waleśkiewicz Ogórek – Management Board Member
Krystian Waleśkiewicz – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Krystian Waleśkiewiczage 47 | 50 | $6,753.11 | 50% |
Karolina Waleśkiewicz Ogórekage 48 | 50 | $6,753.11 | 50% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2018-04-27 to 2022-07-12.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 10, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | PREZYDENT MIASTA BYDGOSZCZ |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| InventionbioS.A. | $17,762,977.76 | inventionbio.pl | ||
| BiotechnaS.A. | $2,472,888.07 | bsbiotechna.com | ||
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| COS LabP.S.A. | $1,028,123.83 | coslab.pl | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| Immbionicsp. z o.o. | $31,756.23 | immbionic.com.pl | ||
| Fusiomicasp. z o.o. | $5,263.98 | fusiomica.com | ||
| Passio Human Microbiomesp. z o.o. | $1,856.58 | passiohumanmicrobiome.com | ||
| Passio Biomaterialssp. z o.o. | $0.00 | passio.pl | ||
| SONO Livesp. z o.o. | – | sonolive.eu |
FAQ
The main business activity of OMC Clinical Research focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on April 25, 2018.
The headquarters is located at: ul. Ks. Zygmunta Trybowskiego 14, 85-796 Bydgoszcz.
The management board consists of: Karolina Waleśkiewicz Ogórek (Member of the Management Board) and Krystian Waleśkiewicz (President of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-04-06